Objective To explore whether magnetotherapy is preventive in retarding diabetic kidney disease（DKD） progression and investigate underling molecular mechanisms related to its therapeutic efficacy. Methods Twenty-eigh...Objective To explore whether magnetotherapy is preventive in retarding diabetic kidney disease（DKD） progression and investigate underling molecular mechanisms related to its therapeutic efficacy. Methods Twenty-eight patients with type Ⅱ diabetes（T2D） were undergone pulsed electromagnetic fields（PEMF） stimulation at the acupoints of Píshū（脾俞 BL 20）, Zúsānl（足三里 ST 36）, Shènshū（肾俞 BL 23） and Yíshū（胰俞, EX-B3） for a period of 4 weeks. Urinary micro-albumin（U-m Alb） excretion, plasma methane dicarboxylic aldehyde（MDA and lipopolysaccharide（LPS） of the patients were used for evaluating therapeutic efficacies. Results After the acumagnetotherapy, U-m Alb excretion in the participated patients was markedly reduced（27.21±3.51 vs 8.51±0.95, P0.001） accompanied with decreased MDA（16.46±1.17 vs 12.40±1.86, P0.05） and LPS（37.41±3.84 vs 21.63±3.61, P0.05） levels in plasma while the metabolic control of these patients was not significantly altered. Acumagnetotherapy increased IκBα content（0.69±1.17 vs 1.30±0.29, P0.01）, an inhibitory protein of inflammatory response, and correspondingly reduced the protein levels of inflammatory activating proteins, NF-κB p65（0.98±0.42 vs 0.43±0.28, P0.05） and NF-κB p50（1.19±0.40 vs 0.76±0.30, P0.05）. The acumagnetotherapy also inhibited the oxidantproducing enzyme, Nox4 protein expression（1.32±0.40 vs 0.37±0.23, P0.05） in patient ＇s blood lymphocytes. Conclusion Short-term intervention of acumagnetotherapy in patients with T2 D mitigates DKD progress potentially by its anti-oxidative and anti-inflammatory effects.展开更多
目的研究栝楼桂枝汤血中移行成分。方法采用HPLC-DAD全波长扫描法,色谱柱:Diamonsial C18(460×250 mm,5μm);流动相:乙腈-0.1%甲酸水梯度洗脱;流速:0.8 m L/min;柱温:30℃;进样量:10μL。结果采用相对保留时间和DAD全波长扫描图相...目的研究栝楼桂枝汤血中移行成分。方法采用HPLC-DAD全波长扫描法,色谱柱:Diamonsial C18(460×250 mm,5μm);流动相:乙腈-0.1%甲酸水梯度洗脱;流速:0.8 m L/min;柱温:30℃;进样量:10μL。结果采用相对保留时间和DAD全波长扫描图相结合,推测大鼠灌胃给药栝楼桂枝汤后含药血清中有22个入血移行成分,并经标品比对鉴定其中16个化合物:没食子酸、氧化芍药苷、芍药苷亚硫酸酯、芍药内酯苷、芍药苷、芹糖甘草苷、甘草苷、五没食子酰葡萄糖、芹糖异甘草苷、异甘草苷、芒柄花苷、甘草素、肉桂酸、苯甲酰芍药苷、异甘草素、甘草酸。结论本研究基于DAD全波长扫描法分析复方血中移行成分,为揭示栝楼桂枝汤在体内抗脑卒中后肢体痉挛与神经保护药效物质提供一定实验依据。展开更多
基金Supported by the Natural Science Foundation of China:81270886
文摘Objective To explore whether magnetotherapy is preventive in retarding diabetic kidney disease（DKD） progression and investigate underling molecular mechanisms related to its therapeutic efficacy. Methods Twenty-eight patients with type Ⅱ diabetes（T2D） were undergone pulsed electromagnetic fields（PEMF） stimulation at the acupoints of Píshū（脾俞 BL 20）, Zúsānl（足三里 ST 36）, Shènshū（肾俞 BL 23） and Yíshū（胰俞, EX-B3） for a period of 4 weeks. Urinary micro-albumin（U-m Alb） excretion, plasma methane dicarboxylic aldehyde（MDA and lipopolysaccharide（LPS） of the patients were used for evaluating therapeutic efficacies. Results After the acumagnetotherapy, U-m Alb excretion in the participated patients was markedly reduced（27.21±3.51 vs 8.51±0.95, P0.001） accompanied with decreased MDA（16.46±1.17 vs 12.40±1.86, P0.05） and LPS（37.41±3.84 vs 21.63±3.61, P0.05） levels in plasma while the metabolic control of these patients was not significantly altered. Acumagnetotherapy increased IκBα content（0.69±1.17 vs 1.30±0.29, P0.01）, an inhibitory protein of inflammatory response, and correspondingly reduced the protein levels of inflammatory activating proteins, NF-κB p65（0.98±0.42 vs 0.43±0.28, P0.05） and NF-κB p50（1.19±0.40 vs 0.76±0.30, P0.05）. The acumagnetotherapy also inhibited the oxidantproducing enzyme, Nox4 protein expression（1.32±0.40 vs 0.37±0.23, P0.05） in patient ＇s blood lymphocytes. Conclusion Short-term intervention of acumagnetotherapy in patients with T2 D mitigates DKD progress potentially by its anti-oxidative and anti-inflammatory effects.
文摘目的研究栝楼桂枝汤血中移行成分。方法采用HPLC-DAD全波长扫描法,色谱柱:Diamonsial C18(460×250 mm,5μm);流动相:乙腈-0.1%甲酸水梯度洗脱;流速:0.8 m L/min;柱温:30℃;进样量:10μL。结果采用相对保留时间和DAD全波长扫描图相结合,推测大鼠灌胃给药栝楼桂枝汤后含药血清中有22个入血移行成分,并经标品比对鉴定其中16个化合物:没食子酸、氧化芍药苷、芍药苷亚硫酸酯、芍药内酯苷、芍药苷、芹糖甘草苷、甘草苷、五没食子酰葡萄糖、芹糖异甘草苷、异甘草苷、芒柄花苷、甘草素、肉桂酸、苯甲酰芍药苷、异甘草素、甘草酸。结论本研究基于DAD全波长扫描法分析复方血中移行成分,为揭示栝楼桂枝汤在体内抗脑卒中后肢体痉挛与神经保护药效物质提供一定实验依据。
